{"id":"W2945103009","doi":"10.1186/s12885-019-5507-6","title":"Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: a systematic review and secondary analysis of trials","year":2019,"lang":"en","type":"review","venue":"BMC Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa","funders":"National Institute for Health and Care Research","keywords":"Medicine; Anaplastic lymphoma kinase; Erlotinib; Oncology; Internal medicine; Atezolizumab; Lung cancer; Epidermal growth factor receptor; Pembrolizumab; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0004964013,0.001009316,0.0155152,0.0006232765,0.00009757579,0.00003069537,0.0001769823,0.0001882475,0.0008306617],"category_scores_gemma":[0.0005545673,0.0005878602,0.001238879,0.001186739,0.000128379,0.0001721707,0.00006583409,0.0001667966,0.000001954388],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008367409,"about_ca_system_score_gemma":0.003429233,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006151253,"about_ca_topic_score_gemma":0.004124312,"domain_scores_codex":[0.9947313,0.0005967398,0.002917134,0.0009507729,0.0003664692,0.0004375906],"domain_scores_gemma":[0.9888264,0.005407093,0.004216291,0.0005342714,0.0007162259,0.0002997465],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00137239,0.0004325839,0.0001395697,0.9398265,0.04177081,0.00001071007,0.001011776,0.00001388131,0.000007875726,0.000006659134,0.0001968478,0.01521039],"study_design_scores_gemma":[0.01692253,0.002114306,0.0003796904,0.3673683,0.6088333,0.00002064225,0.000438949,0.000438417,0.000161136,0.000002539563,0.0024912,0.0008289604],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004305732,0.9454897,0.0001495525,0.00001626447,0.0003449568,0.01863204,0.03099898,0.0000179371,0.00004482739],"genre_scores_gemma":[0.0007889833,0.9864116,0.001494471,0.00006952577,0.00007106748,0.007069269,0.00128544,0.00008938424,0.002720199],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5724581,"threshold_uncertainty_score":0.9996573,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1126703746187524,"score_gpt":0.4312807990143271,"score_spread":0.3186104243955747,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}